These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1005 related articles for article (PubMed ID: 12810676)
1. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
2. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322 [TBL] [Abstract][Full Text] [Related]
3. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403 [TBL] [Abstract][Full Text] [Related]
6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189 [TBL] [Abstract][Full Text] [Related]
8. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936 [TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice. Floyd HS; Jennings-Gee JE; Kock ND; Miller MS Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519 [TBL] [Abstract][Full Text] [Related]
11. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Gilley J; Fried M Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876 [TBL] [Abstract][Full Text] [Related]
12. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681 [TBL] [Abstract][Full Text] [Related]
13. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082 [TBL] [Abstract][Full Text] [Related]
16. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
17. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Wang Y; Zhang Z; Kastens E; Lubet RA; You M Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609 [TBL] [Abstract][Full Text] [Related]
18. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. Brenner AJ; Paladugu A; Wang H; Olopade OI; Dreyling MH; Aldaz CM Clin Cancer Res; 1996 Dec; 2(12):1993-8. PubMed ID: 9816158 [TBL] [Abstract][Full Text] [Related]
19. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis. Tang S; Luo H; Yu J; Yang D; Shu J Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389 [TBL] [Abstract][Full Text] [Related]
20. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Krimpenfort P; Quon KC; Mooi WJ; Loonstra A; Berns A Nature; 2001 Sep; 413(6851):83-6. PubMed ID: 11544530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]